COVID-19 AND NEUROMUSCULAR DISEASE
This paper, recently published in Revue Neurologique, summarises recommendations for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network (FILNEMUS). In France, the epidemic phase of COVID-19 caused by SARS-CoV-2 resulted in the implementation of emergency measures and an impact on the organisation of neuromuscular reference centers. In this particular context, the FILNEMUS has established guidance in an attempt to harmonise management of neuromuscular patients within France.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167585/
by Marialuisa Zedde and Francesco Cavallieri
